First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study | British Journal of Cancer
Combination extends OS in metastatic colorectal cancer
NEJM on X: "This editorial describes the science behind a clinical trial performed by Prager and colleagues: a test of trifluridine–tipiracil and bevacizumab to treat patients with refractory metastatic colorectal cancer. https://t.co/Y1QlV28qsr" /
Avastin and Lonsurf for Advanced Colorectal Cancer - NCI
How does chemo fit into my treatment plan? - Colontown University
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer? - The Lancet Oncology
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia - Price - 2020 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
4. Cancer colorectal métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
Servier et Taiho Oncology présentent des données sur la survie globale de trifluridine/tipiracil (LONSURF®) en association avec le bevacizumab chez des patients atteints d'un cancer colorectal métastatique réfractaire... | Business Wire
NCCN® Guidelines for Metastatic Colon Cancer Treatment
How to Take LONSURF® (trifluridine and tipiracil) tablets | Helpful Dosage Reminders
Servier et Taiho Oncology présentent des données sur la survie globale de trifluridine/tipiracil (LONSURF®) en association avec le bevacizumab chez des patients atteints d'un cancer colorectal métastatique réfractaire... | Business Wire
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study | British Journal of Cancer
La trifluridine plus le tipiracil et le bévacizumab est une nouvelle norme de soins pour le cancer colorectal métastatique réfractaire
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer | NEJM
Lonsurf® Treatment for Colorectal Cancer - CancerConnect
These highlights do not include all the information needed to use LONSURF safely and effectively. See full prescribing information for LONSURF. LONSURF (trifluridine and tipiracil) tablets, for oral use Initial U.S. Approval:
Benefits & Risks of Treatment | Metastatic Colorectal Cancer (mCRC)| Avastin® (bevacizumab)
La trifluridine plus le tipiracil et le bévacizumab est une nouvelle norme de soins pour le cancer colorectal métastatique réfractaire
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer | NEJM
Trifluridine/Tipiracil Combination Misses Mark in Metastatic Colon Cancer | MedPage Today
Continued Avastin Extends Survival After 1st Progression in Colorectal Cancer - CancerConnect
Trifluridine/Tipiracil in Previously Treated Metastatic Colorectal Cancer - The ASCO Post
Servier : AMM européenne pour LONSURF en association au bevacizumab dans le cancer colorectal métastatique réfractaire | MyPharma Editions
Nanotechnologies for the treatment of colon cancer: From old drugs to new hope - ScienceDirect
Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer
La FDA approuve Lonsurf plus bevacizumab pour le traitement du cancer colorectal métastatique
